Edwards Lifesciences Corporation(EW US)
$89.07-1.021.13%Ext:$92.59+3.523.95%(Market Closed · 00:00:03 UTC)
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY199912/31/1999 | FY200012/31/2000 | FY200112/31/2001 | FY200212/31/2002 | FY200312/31/2003 | FY200412/31/2004 | FY200512/31/2005 | FY200612/31/2006 | FY200712/31/2007 | FY200812/31/2008 | FY200912/31/2009 | FY201012/31/2010 | FY201112/31/2011 | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1,402.4 | 4,169.7 | 1,069.4 | 1,093.7 | ||||||||||||||||||||||||||
| Depreciation & Amortization | 144.9 | 155.2 | 156.6 | 160.9 | ||||||||||||||||||||||||||
| Stock Based Compensation | 139.4 | 162.3 | 158.1 | 163.3 | ||||||||||||||||||||||||||
| Change in Working Capital | -526.3 | -259.3 | 154.6 | -305.4 | ||||||||||||||||||||||||||
| Other Non-Cash Items | 7.5 | -3,362.2 | 174.1 | 330.0 | ||||||||||||||||||||||||||
| Net Cash from Operating Activities | 895.8 | 542.3 | 1,595.2 | 1,358.6 | ||||||||||||||||||||||||||
| -Investments in Property, Plant & Equipment | -266.3 | -282.4 | -260.2 | -269.1 | ||||||||||||||||||||||||||
| -Acquisitions Net | -95.2 | -1,061.8 | - | -35.1 | ||||||||||||||||||||||||||
| -Purchases of Investments | -105.5 | -945.8 | -3,135.1 | -3,141.4 | ||||||||||||||||||||||||||
| Sales/Maturities of Investments | 715.8 | 857.6 | 2,878.1 | 2,772.8 | ||||||||||||||||||||||||||
| Other Investing Activities | -75.0 | 3,745.3 | -195.7 | -218.2 | ||||||||||||||||||||||||||
| Net Cash from Investing Activities | 173.8 | 2,312.9 | -712.9 | -891.0 | ||||||||||||||||||||||||||
| Net Debt Issuance | -0.3 | - | - | - | ||||||||||||||||||||||||||
| Net Stock Issuance | -879.6 | -1,159.4 | -719.3 | -252.5 | ||||||||||||||||||||||||||
| -Net Dividends Paid | - | - | - | - | ||||||||||||||||||||||||||
| Other Financing Activities | 168.9 | 176.4 | -237.5 | -897.5 | ||||||||||||||||||||||||||
| Net Cash from Financing Activities | -711.0 | -983.0 | -956.8 | -1,150.0 | ||||||||||||||||||||||||||
| Effect of Forex Changes | 16.8 | 38.6 | -44.8 | -18.9 | ||||||||||||||||||||||||||
| Net Change in Cash | 375.4 | 1,910.8 | -119.3 | -701.3 | ||||||||||||||||||||||||||
| Cash at End of Period | 1,148.0 | 3,058.8 | 2,939.5 | 11,371.8 | ||||||||||||||||||||||||||
| Operating Cash Flow | 895.8 | 542.3 | 1,595.2 | 1,358.6 | ||||||||||||||||||||||||||
| -Capital Expenditure | -266.3 | -252.4 | -260.2 | -269.1 | ||||||||||||||||||||||||||
| Free Cash Flow | 629.5 | 289.9 | 1,335.0 | 1,089.5 | ||||||||||||||||||||||||||